Cancer screenings proto

General Details:

Name:: Cancer screenings proto
Steward:: PhenX
Definition:: These self-administered questions ask about different cancer screening tests a respondent may have had in the past 3 years. The protocol includes the following screenings: mammogram, pap smear, pelvic examination, Prostate Specific Antigen (PSA) test, colonoscopy, ultrasound of the ovaries, barium enema, chest x-ray, sigmoidoscopy, and digital rectal examination. All respondents are asked questions 1-3. Only female respondents are asked questions 4-8, and only male respondents are asked questions 9 and 10. While not currently performed as part of routine cancer screening, the Working Group recommends including questions about two additional cancer screening procedures: Helical computed tomography (CT) scan and whole body scan.
Registration Status:: Qualified

Definition:: These self-administered questions ask about different cancer screening tests a respondent may have had in the past 3 years. The protocol includes the following screenings: mammogram, pap smear, pelvic examination, Prostate Specific Antigen (PSA) test, colonoscopy, ultrasound of the ovaries, barium enema, chest x-ray, sigmoidoscopy, and digital rectal examination. All respondents are asked questions 1-3. Only female respondents are asked questions 4-8, and only male respondents are asked questions 9 and 10. While not currently performed as part of routine cancer screening, the Working Group recommends including questions about two additional cancer screening procedures: Helical computed tomography (CT) scan and whole body scan.
Tags:: Source: Regenstrief LOINC

ID:
Title:
URI:
Provider Org:
Language Code:: en-US
Document:: U.S. Department of Health and Human Services. National Institutes of Health. National Cancer Institute. Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Baseline Questionnaire for Male Participants (BQM3). Version Date: 10/99, page 6, questions 44 and 45 (source for questions 3, 9, and 10). U.S. Department of Health and Human Services. National Institutes of Health. National Cancer Institute. Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Baseline Questionnaire for Female Participants (BQF3). Version Date: 10/99, pages 6–7, questions 55–62 (source for questions 1 and 2, 4–8).

Key:

Related Names

Value:

Key:

Related Codes

Value:

Code System	Code	Code Text	Code Version
https://www.phenxtoolkit.org	70901	cancer_screenings

Key:

Fully-Specified Name

Value:

Component	Property	Time	System	Scale	Method
PhenX - cancer screenings protocol 070901	-	Pt	^Patient	-	PhenX

Key:

Basic Attributes

Value:

Class	Type	First Released	Last Updated	Change Reason	Panel Type
PANEL.PHENX	Clinical	Version 2.36	Version 2.66	Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.	Panel